Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuromodulation
MedTech
Abbott begins neuromodulation trial in drug-resistant depression
The FDA previously granted Abbott a breakthrough designation for aiming the technology toward the areas of the brain that regulate mood.
Conor Hale
Sep 4, 2024 11:02am
Urinary incontinence neuromod newcomer Amber nets $100M
Jun 10, 2024 4:40pm
Mainstay Medical merits $125M for back pain neuromod implant
Feb 28, 2024 12:07pm
FDA expands OK for Boston Sci WaveWriter spinal cord stimulators
Feb 6, 2024 12:28pm
Cognito opens biomarker study of neuromod device in Alzheimer’s
Jan 23, 2024 10:45am
JPM24: Boston Scientific drops $3.7B on neuromod player Axonics
Jan 8, 2024 10:12am